Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07560618 · ClinicalTrials.gov registry record · Phase 4
Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
A Phase 4 study, sponsored by Integrative Skin Science and Research.
- Not yet
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT07560618 is a Phase 4 study that has not yet begun recruiting, run by Integrative Skin Science and Research. The registered enrollment target is 40 participants.
The verdict
NCT07560618, a Phase 4 study, has not yet begun recruiting, sponsored by Integrative Skin Science and Research.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is being done to obtain descriptive classifications of pruritus using a patient directed survey system and assess change in pruritus over time in patients with Atopic Dermatitis over 4 weeks with use of topical Roflumilast cream 0.15% QD.
Interventions
- DRUG Roflumilast Cream 0.15%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-04 |
| Est. Completion | 2027-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07560618
The ClinicalTrials.gov registry entry for NCT07560618 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integrative Skin Science and Research, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Roflumilast Cream 0.15% is the first listed.
NCT07560618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07560618 about?
NCT07560618 is a clinical study titled "Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.". This study is being done to obtain descriptive classifications of pruritus using a patient directed survey system and assess change in pruritus over time in patients with Atopic Dermatitis over 4 weeks with use of topical Roflumilast cream 0.15% QD.
What is the current status of trial NCT07560618?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2026-04. Estimated completion is 2027-08.
What interventions are being tested in trial NCT07560618?
The interventions under investigation include: Roflumilast Cream 0.15% (DRUG).
Who is sponsoring clinical trial NCT07560618?
This trial is sponsored by Integrative Skin Science and Research, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.